Personality pathology, depression and HPA axis functioning

Human Psychopharmacology

Volumn 16, Issue 4, 2001, Pages 303-308

  Schweitzer, I ^a,b   Tuckwell, V ^a   Maguire, K ^a   Tiller, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Albert Road Clinic ^*  (Australia)

Author keywords

DST; MCMI II; MDD; Personality

Indexed keywords

DEXAMETHASONE;

ANALYSIS; ARTICLE; AVOIDANCE BEHAVIOR; BORDERLINE STATE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEASUREMENT; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PRIORITY JOURNAL; SAMPLE; SCHIZOIDISM; SCORING SYSTEM; SYMPTOM;

EID: 0034933399     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.297     Document Type: Article

References (33)

1. Dexamethasone suppression test and MPI scales
2. The dexamethasone suppression test for diagnosis and prognosis in psychiatry
3. The dexamethasone suppression test in depressive illness: Clinical correlates
4. Personality disorder, symptoms and dexamethasone suppression in depression
5. Response to dexamethasone and subtype of depression
6. The psychological correlates of the DST in depressed patients
7. A specific laboratory test for the diagnosis of melancholia: Standardisation, validation, and clinical utility
8. The dexamethasone suppression test for melancholia
9. Personality traits and disorder in depression
10. Validity of the Millon Clinical Multiaxial Inventory in the assessment of affective disorders
11. Separation of subtypes of depression using discriminant analysis. I. Separation of unipolar endogenous depression from non-endogenous depression
12. A rating scale for depression
13. Personality attributes and affective disorders
14. Depression and the Newcastle scale. Their relationship to the dexamethasone suppression test
15. Identification of depression in children and adolescents: The role of the dexamethasone suppression test
16. Dexamethasone kinetics in depressed patients before and after clinical response
17. Interpretive guide to the Millon Clinical Multiaxial Inventory (MCMI-II)
18. A new depression scale designed to be sensitive to change
19. Symptom profile of patients with positive DST: A pilot study
20. DST and TRH tests in borderline personality disorder
21. MMPI, personality dysfunction and the dexamethasone suppression test in major depression
22. Sub-typing depression, III. Development of a clinical algorithm for melancholia and comparison with other diagnostic measures
23. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioural symptoms
24. HPA axis function and temperament in depression: A negative report
25. Hypothalamic-pituitary-adrenal axis activity in depressive illness: Its relationship to classification
26. The dexamethasone suppression test in anorexia nervosa: The influence of weight, depression, adrenocorticotrophic hormone and dexamethasone
27. Depression, borderline disorder, and the DST
28. Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy
29. Diagnosis and psychopathology in psychiatric patients resistant to dexamethasone
30. The dexamethasone suppression test and depression: A study in a normal population
31. The validity of the dexamethasone suppression test as a marker for endogenous depression